Cutler Group LP Dbv Technologies S.A. Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 07, 2020	BUY	$2.33 - $12.98 $3,495 - $19,470	1,500 New	1,500 $0
Q4 2018 Feb 05, 2019	SELL	$5.75 - $21.85 $13,800 - $52,440	-2,400 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$16.81 - $24.58 $26,895 - $39,328	-1,600 Reduced 40.0%	2,400 $8,000
Q2 2018 Aug 10, 2018	BUY	$18.6 - $24.94 $44,640 - $59,856	2,400 Added 150.0%	4,000 $1,000
Q1 2018 May 11, 2018	SELL	$20.86 - $26.6 $154,364 - $196,840	-7,400 Reduced 82.22%	1,600 $0
Q4 2017 Jan 17, 2018	SELL	$20.9 - $49.36 $359,480 - $848,992	-17,200 Reduced 65.65%	9,000 $11,000
Q3 2017 Oct 17, 2017	BUY	$39.62 - $46.17 $1.04 Million - $1.21 Million	26,200	26,200 $225,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $571M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.